Skip to main content
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Multimedia
All Videos
Best Practices in Breast Cancer Therapy | OFS
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Multimedia
All Videos
Best Practices in Breast Cancer Therapy | OFS
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
Drug Updates
Empliciti (Elotuzumab): First SLAMF7 Antibody Therapy Approved for the Treatment of Patients with Previously Treated Multiple Myeloma
By
Lisa A. Raedler, PhD, RPh
Drug Updates
May 2016, Vol 6, No 5
Read More ›
Darzalex (Daratumumab): First Anti-CD38 Monoclonal Antibody Approved for Patients with Relapsed Multiple Myeloma
By
Lisa A. Raedler, PhD, RPh
Drug Updates
,
Hematologic Malignancies
,
Multiple Myeloma
April 2016, Vol 6, No 4
Read More ›
Ninlaro (Ixazomib): First Oral Proteasome Inhibitor Approved for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
By
Lisa A. Raedler, PhD, RPh
Drug Updates
March 2016, Vol 6, No 3
Read More ›
Onivyde (Irinotecan Liposome Injection) a New Treatment Option for Patients with Metastatic Pancreatic Cancer
By
Lisa A. Raedler, PhD, RPh
Drug Updates
February 2016, Vol 6, No 2
Read More ›
Keytruda (Pembrolizumab) First PD-1 Inhibitor Approved for the Treatment of Patients with Metastatic Non–Small-Cell Lung Cancer Expressing PD-L1
By
Lisa A. Raedler, PhD, RPh
Drug Updates
January 2016, Vol 6, No 1
Read More ›
Ibrance (Palbociclib): First CDK4 and CDK6 Inhibitor FDA Approved for the Treatment of Postmenopausal Women with Metastatic Breast Cancer
By
Lisa A. Raedler, PhD, RPh
Breast Cancer
,
Drug Updates
October 2015, Vol 5, No 7
Read More ›
Farydak (Panobinostat): First HDAC Inhibitor Approved for the Treatment of Patients with Relapsed Multiple Myeloma
Drug Updates
,
Multiple Myeloma
,
Hematologic Malignancies
September 2015, Vol 5, No 6
Read More ›
Jakafi (Ruxolitinib): First FDA-Approved Medication for the Treatment of Patients with Polycythemia Vera
By
Lisa A. Raedler, PhD, RPh
Drug Updates
June 2015, Vol 5, No 5
Read More ›
Akynzeo (Netupitant and Palonosetron), a Dual-Acting Oral Agent, Approved by the FDA for the Prevention of Chemotherapy-Induced Nausea and Vomiting
By
Lisa A. Raedler, PhD, RPh
Drug Updates
May 2015, Vol 5, No 4
Read More ›
Sunitinib Associated with Higher Costs Compared with Pazopanib in Patients with RCC
By
Chase Doyle
Drug Updates
May 2015, Vol 5, No 4
Read More ›
Page 3 of 4
1
2
3
4